Vietnam Veterans and PTSD (Post Traumatic Stress Disorder ...
David Stamps CoANA Spring Meeting 4 May, 2013. o PTSD: Post-traumatic stress disorder is a severe...
-
Upload
kristian-jennings -
Category
Documents
-
view
215 -
download
2
Transcript of David Stamps CoANA Spring Meeting 4 May, 2013. o PTSD: Post-traumatic stress disorder is a severe...
Perioperative Anesthesia for Patients with Post-Traumatic Stress Disorder
David StampsCoANA Spring Meeting4 May, 2013
PTSD Defined
o PTSD: Post-traumatic stress disorder is a severe anxiety disorder that can develop after exposure to any event that results in psychological trauma
o DSM: development of characteristic symptoms following exposure to an extreme traumatic stressor involving direct personal experience of an event that involves actual or threatened death or serious injury, or other threat to one's physical integrity; or witnessing an event that involves death, injury, or a threat to the physical integrity of another person; or learning about unexpected or violent death, serious harm, or threat of death or injury experienced by a family member or other close associate (Criterion A1)
PTSD DSM
o Hyperarousal symptoms• Difficulty sleeping• Irritability/anger outbursts• Difficulty concentrating• Hypervigilance• Exaggerated startle response
Hamblen, PhD
PTSD DSM
o Re-experiencing symptoms• Recurrent recollections of event• Recurrent distressing dreams of event• Acting or feeling as if event were occurring• Psy distress at cues resembling event• Psy reactivity to cues
Hamblen, PhD
PTSD DSM
o Avoidance/numbing symptoms• Avoiding thoughts/feelings/conversations• Activities/places/people that cause reminders• Inability to recall part of trauma• Decreased interest in activates• Estrangement• Restricted range of affect• Sense of foreshortened future
Hamblen, PhD
National Comorbidity Surveyo Early 1990's
o Interviews of a representative national sample of 8,098 Americans
o Age 15 to 54 years
o Lifetime PTSD was 7.8% general population• Women (10.4%)• Men (5%)
PTSD Prevalence (NCS-R)o Lifetime PTSD prevalence = 6.8%• 9.7% women• 3.6% men
o Current past year PTSD prevalence = 3.6%• 5.2% women• 1.8% men
Kessler et al, 2005.
Prevalence Among Children and Adolescentso No population-based epidemiological studies• Studies examined prevalence of PTSD high-risk children;
experienced specific traumatic events, such as abuse or natural disasters• May have a higher prevalence of PTSD than adults in the general
population
• (2003) – Prevalence of PTSD among adolescents• National Survey of Adolescents
• Household probability sample of 4,023 adolescents between the ages of 12 and 17• DSM-IV criteria for PTSD: • Six-month prevalence was estimated to be 3.7% for boys and 6.3% for
girls
National Center for PTSD
Conditional Risk
o 20% of exposed women and 8% of exposed men develop PTSD
o Trauma most likely to cause development• Rape• Physical abuse• Molestation• Threat (weapon)• Sudden loss of a loved one
Kessler et al. 2005
Combat Exposure
o NCS-R• Lifetime prevalence of PTSD = 39% Male combat
veterans• Male combat vs all other male trauma• Higher lifetime PTSD prevalence• Greater likelihood of delayed prevalence• Greater likelihood of unresolved symptoms
Keesler et al 2005
Post-Operative Definitionso Postoperative Delirium • Acute change in cognition• 24 to 72 hours after surgery• Decreased ability to focus, sustain, or shift
attention• Not explained by preexisting/evolving disorder
i.e. dementia or psychosis
Definitions
o Emergence Delirium (ED) • Psychomotor agitation • Ranging from frequent, nonpurposeful
movement to overt physical aggressiveness • Immediately or shortly after emergence from
anesthesia• Self-limited, may last from minutes to hours
Definitions
o Postoperative Cognitive Dysfunction Decline in cognitive functioning that manifests
after surgery Patient must demonstrate new-onset impaired
functioning that:▪ Affects at least 2 cognitive processes ▪ Persisted for at least 2 weeks,▪ Has been confirmed by some form of objective testing▪ Accompanies a general medical condition or nervous
system dysfunction▪ Not better explained by the presence of▪ Delirium, dementia, or amnestic disorder
Incidence of ED
o Emergence Delirium• 4.7% to 21.3% of adults after general anesthesia• Identified risk factors • Preoperative administration of benzodiazepines• Untreated postoperative pain• PTSD NOT mentioned
o Emergence delirium is associated with multiple adverse outcomes• Self-extubation, unintended removal of lines/tubes,
injury to patient/staff, longer stays PACU• Not associated with greater postoperative mortality in a
population of mixed ages (unlike postoperative delirium)
Anesthetic Care of PTSD Ptso Can you devise an anesthetic plan for your
PTSD Pt?• We’ll build toward this
o What research is out there to guide you?• Little to none
o Can you treat PTSD with anesthesia?• Lets address this first
PTSD/Stellate Ganglion Block (SGB)o History• 2003, a published report demonstrated a reduction in
PTSD-associated anxiety by clipping the sympathetic ganglia, via an endoscopic sympathetic block (ESB) at the second thoracic vertebra (T2)
• Most recently, the first successful use of a stellate ganglion block (SGB) for the treatment of PTSD was reported in 2008. Lipov EG, Joshi JR, Lipov SG, Sanders SE, Siroko MK. • Cervical sympathetic blockade in a patient with
posttraumatic stress disorder: a case report. Ann Clin Psychiatry. 2008;20:227–228.10
PTSD/SGB
o PTSD causes an increase in nerve growth factor (NGF)• NGF: protein important part of the development/
survival of nerve cells, especially sensory neurons like those that transmit pain, touch and temperature
• An elevation in NGF has been linked to episodes that stimulate adrenaline
• Growth of nerve shoots/sprouts in the brain=increase in norepinephrine levels
• Lead to the development of pathological states• Local anesthetic injected near the stellate ganglion
reverses this domino effect by lowering NGF concentration
1. Precipitating event, estrogen decrease, nerve trauma, PTSD triggering event
2. NGF increase
3. Retrograde transport of the NGF
1. NGF increase in the stellate ganglion
2. Sprouting of the sympathetic fibers distally
3. Increase in the brain norepinephrine
1. Stellate ganglion block
2. Reduction of NGF decrease in sprouting, reduction of brain norepinephrine and resolution of symptoms
PTSD/SGB
o Study Objective: Report the successful use of stellate ganglion blocks (SGBs) in two patients experiencing symptoms PTSD
o The Post-traumatic Stress Disorder Checklist (PCL) • 17-item psychometric test commonly used to screen
for PTSD
o The PCL administered day prior to treatment, to establish a baseline, day after treatment. The PCL was also utilized during follow-up visits to quantify the patient’s symptomotology
PTSD/SGB: Case 1
o 46-year-old Hispanic male recently retired from the military. Symptoms commenced in the first Gulf War following a close-quarters combat event in an Iraqi-held bunker
o 10 enemy combatants were killed at close range
o Briefly rendered unconscious from an explosion
o The patient was not visibly injured in the assault
PTSD/SGB: Case 1
o In the care of a psychiatrist for over one year
o Medications• Sertraline, quentiapine, trazadone, venlafaxine, and
zolpidem• Quentiapine was prescribed to control PTSD-related
nightmares
o Never diagnosed with any type of thought disorder or other psychotic condition
o Initial pre-injection PCL score was 76/85
o He recounted that since his trigger event he could not recall a time when he slept for more than 2 to 3 hours
PTSD/SGB: Case 2
o 36 year old white male active duty service member• Battle of Fallujah during Operation Iraqi Freedom• Engaged in killing enemy combatants at close range exposed to
“hundreds” of civilian and combatant dead
o In the care of a psychiatrist for 1 year before his SGB
o Symptoms included• Pronounced anxiety symptoms-shortness of breath, heart palpitations,
poor sleep, and nightmares• The patient’s anxiety symptoms were in direct response to a triggering
event, and do not appear to be related to a co-morbid diagnosis
o Medications• Mirtazapine, sertraline, and zolpidem
o His pre-SGB PCL score was 54/85
PTSD/SGB: Case Study Resultso Both patients experienced immediate,
significant and durable relief as measured by the PCL (score minimum 17, maximum 85)• Pt 1:• PCL=25, after 7 months PCL=67• Repeat SGB brought PCL to 23, leveled out at 34• Five minutes after SGB “a cloud had lifted” from his mind• Global feelings of anxiety 8 out of 10 to a 2 out of 10 • Great deal of satisfaction • First time since his symptoms started (18 years ago) he
was able to sleep for 6 to 7 hours • Nightmares diminished in both intensity and frequency
PTSD/SGB: Case Study Resultso Pt 2:• Post- injection PCL score =24• Seven months after SGB, PCL score consistent 24.• Patient’s spontaneous comments • “I feel at peace” • “I’m just starting to be aware of how much anxiety I
have been living with” • “My mind is not racing” • He reports feeling like himself, and no longer feels “like
an unpleasant person” • His erectile dysfunction resolved when he discontinued
medications
PTSD/SGB: Case Study Resultso In both instances, the pre-treatment score
suggested a PTSD diagnosis whereas the post-treatment scores did not
o Both patients discontinued all antidepressant and antipsychotic medications while maintaining their improved PCL score
Anesthetic Care of PTSD Ptso Can you devise an anesthetic plan for your PTSD
Pt?• We’ll build toward this
o What research is out there to guide you?• Little to none
o Can you treat PTSD with anesthesia?• Lets address this first
PTSD Study/Military CRNA’s
o Aug 2012 Qualitative study• Describe experiences of 3 Army CRNA’s• Pts with Traumatic Brain Injury (TBI)/PTSD• All pts undergoing general anesthesia• All cases post 9/11• CRNA’s observed cases of pts awakening in
Delirium (10%)• Describe your experiences• Thought processes as to why delirium occurs
Military CRNA’s
o Emergence Delirium defined by study CRNA’s• Pt awakes in violent and thrashing manner• Attempts at self extubation, breath holding, IV
line displacement, assault on OR staff, the want to flee
• Behavior could occur at anytime from end of surgery to the end of PACU stay
Military CRNA’s
o Five themes emerged• Emergence delirium (ED) exists, and to a greater
extent in military personnel.• ED more prevalent in younger population.• TIVA was superior GA for TBI/PTSD pts• Talking to pts pre induction and on emergence
vital• Profound impact of Ketamine
Military CRNA’s
1. ED exists and to higher degree in military than general population
All CRNA’s experienced ED in the target population
All have years of civilian experience and do not see this in that population (extent or degree)
Military CRNA’s
2. ED more prevalent in younger population Could be mere fact that young men are more
prevalent in targeted population Older personnel have greater experience and
time to develop coping strategies
Military CRNA’s
3. TIVA superior to potent inhalational anesthetic
All 3 CRNA’s would preferentially use TIVA for known PTSD/TBI
One says “less than 1% of my TIVA pts have ED”
Military CRNA’s
4. Talking preoperatively/during emergence to Pts
All three CRNA’s agreed beneficial to offer reassuring words to pts before induction
Room quite, reorientation upon emergence Things we all do but with a heightened
awareness than our average pt
Military CRNA’s
5. Ketamine for PTSD/TBI Has role in alleviating ED One CRNA uses 1mg Ketamine per 10mg
Propofol and sufenta Another uses 100mg Ketamine/100mg Propofol
induction and then TIVA
USAFA/VA PTSD/ED experienceo Case Study of USAFA/VA pt with ED• 26 Y/O white male for excision lipomas• VSS, 70”, 235 lbs• Meds• Cyclobenzaprine/Gabapentin/Omeprazole/Prazosin/
Sertraline/Trazadone• KNDA
USAFA/VA PTSD/ED experienceo Med Hx• Tobacco/HTN/GERD/Arthritis• PTSD/TBI
o Surg Hx• Appy/Lipoma• Hx of “waking up” during procedure• Hx of “combative” wakeup
o Anesth plan• LMAC
USAFA/VA PTSD/EDexperienceo Anesthetic• Midazolam2mg/Fentanyl 100Mcg Preop• Propofol infusion, 350mg total• Total case time 58 min• Fast track to ASU as pt appeared to be GTG• 1443 shortly after arrival to ASU• Pt flashback to Iraq war, not orientated to current
date, place, or situation. Taken to PACU for observation
USAFA/VA PTSD/ED experienceo PACU Stay• Immediately given 2mg Midazolam• Usable to take initial vital signs as pt combative
and trying to get out of gurney• Asking for location of other soldiers/blood
identification• Pts escort brought to bedside, 2:1 care, constant
reorientation to place/time/situation• Back to ASU at 1448
USAFA/VA PTSD/ED experienceo Discharge from SDS center• 1622• Orientated to place/time/situation• Call back 0955 next day• Slept well• No recall of ED event or any events that happened
after initial midazolam dose preop
o Negative impact• Time, personnel, danger to self and others
USAFA/VA PTSD/ED Case 1o 66 y/o male, ASA III, Prostate Bx
o Violent wake-ups last 2 anes (2 OR personnel to ER)
o Med Hx: OSA/COPD/CAD/HTN/DM/Bipolar/PTSD
o Surg Hx: Cardiac Stent ‘01/Colonoscopy ’12
o Hx of Military assassin/hand to hand combat
USAFA/VA PTSD/ED Case 1o Anes plan: Propofol/ketamine heavy
sedation• 15 min procedure with local most stimulating• Load 100mg Propofol/50mg Ketamine, followed by 2-
3cc bolus strait Propofol• Stopped dosing when local in (10 more minutes)• Total 200mg Propofol/50mg Ketamine
• Fast tracked to ASU, awake, reports “best anes I've had. I don’t feel angry or scared”
• Pain 0/10, Sao2 99%• D/C to home within 1 hr, no ill effects over night, was
“out of it for 24 hrs”
USAFA/VA PTSD/ED Case 1o 35 y/o male, ASA II, gang cyst exc right wrist
o Discussed anes options:• IV Nl surg pref, Lmac not option(per pt), GA
o Med Hx:Tobacco/DM type 2/PTSD/Depression
o Surg Hx: knee arthroscopy ’09, no A/C
o Pt and wife both express concerns about any alternative other than GA (preference)
USAFA/VA PTSD/ED Case 1o Pre-op with 2mg Versed/Fentanyl 100mcgo 1402-Induction Propofol 200mg/lidocaine 50mg/Ketamine
50mg. iGel placed (BIS at 20)o 1417-Propofol/Ketamine at 80mcg/kg/min o 1425 BIS at 29 and pt light, increased infusion to
125mcg/kg/mino 1438 infusion offo 1444 surgery completeo 1449 pt extubated, stable, SV, to PACU calm/alert Total
Propofol 400mg/Ketamine 100mg
USAFA/VA PTSD/ED Case 1o Ketorolac 30mg at end of case
o PACU stay uneventful with D/C to home within 1.5 Hrs. Follow up in AM showed no ill effects with high satisfaction with anesthesia
Anesthetic Care of PTSD Ptso Can you devise an anesthetic plan for your
PTSD Pt?• We’ll now explore this
o What research is out there to guide you?• Little to none
o Can you treat PTSD with anesthesia?• Lets address this first
PTSD/Perioperative Management
o Comorbiditieso Substance abuseo Chronic pain
o Psychoactive medso Anxiety concernso Cognitive function
Perioperative Care
o Comorbidities• Cardiac risk factors (lifestyle factors)• HTN/DM/HLP• COPD/OSA/GERD/Obesity
• Depression• 36% in PTSD pts• 3.5% non• PTSD pts• PTSD/Depression may share common genetic basis
o Substance abuse (veteran study)• Tobacco 3X• ETOH 5X• MJ• Medical/Rec
• Illegal drugs 3X
Perioperative Care
o Chronic pain• Encourage Nx staff to educate pt on taking opioids
preop• Pain eval DOS ASAP
o Psychoactive meds• Careful consideration of medication list• SSRI• SNRI• MAO’s• TCA• Alpha antagonists• Anticonvulsants/Benzo’s• Anitpsychotics
Perioperative Care
o Anxiety considerations• Establishing trust and full explanations• Avoidance of loud noises• Wake pt with verbal stimulus vs touch• Elicit and known triggers• Elicit known wake-up patterns
Perioperative Care
o Cognitive function• PTSD has worse preoperative cognitive function• Measures of verbal memory
• Cognitive function found to be inversely related to PTSD symptoms • Retain/learn new info for short period• Manipulate the info in meaningful way• Produce response based on manipulated info• Decreased cognitive reserve (vs overall intelligence) • Pts vulnerable to post-op cognitive decline
Perioperative Care
o PTSD NOT a predictor of:• Length of hospital stay• Readmission rate• Certain surgery specific outcomes
o PTSD NOT known to exacerbate symptoms• Studies limited• Only anecdotal cases of surgery exacerbating
symptoms when aspects of perioperative exp similar to the pts traumatic experience
Perioperative Care
Preoperative evaluation Elicit history of PTSD Dx, sleep
disturbances/nightmares▪ Amitriptyline/sertraline
Younger troops much more common than older Vets to have ED
Elicit history of previous anesthetic experiences of ED
Plan care with PACU for this PTSD pt
Perioperative care
Anesthetic Plan Regional L/MAC if possible TIVA for GA▪ Avoidance of Midazolam▪ Propofol/ketamine mix▪ Adequate pain control; especially as many are chronic
pain pts▪ Consider NSAID and long acting opioid ie: morphine
▪ Consider an alpha 2 agonist (dexmetatomidine)▪ Decreases sympathetic tone/cascade
▪ Awake with verbal stimulus/avoid touching head for stimulus
PACU
One-on-one care if possible
Quiet, non-stimulating environment(good luck)
Family in PACU if possible
Frequent reorientation
Consider avoidance of midazolam for emergence delirium Tends to make pts worse or have no effect
Current Research
o Developing Anesthesia as Post Traumatic Stress Disorder (PTSD) Therapy
o Southern California Institute for Research and Education o National Institute of Mental Health (NIMH)
• Purpose This preclinical phase 1 development study in healthy volunteers seeks to identify if low doses of commonly used non-triggering anesthetic agents might have clinical utility for modulating emotional memory processing and to understand the nature of the brain mechanisms of drug action. Optimally, a drug, dose and brain mechanism of action will be identified that will form the foundation for future use in clinical studies of patients with PTSD
• Drug: DexmedetomidineDrug: PropofolDrug: KetamineDrug: Nitrous Oxide
• A low dose of medication is used during scanning after dose piloting outside the scanner for memory effects and tolerability
Current Research
o Ketamine as a Rapid Treatment for Post-traumatic Stress Disorder (PTSD) (KetPTSD)
o Dennis Charney
o Collaborator:• Department of Defense• Purpose The objective of the proposed study is
to test if a single IV dose of ketamine (0.5 mg/kg) decreases symptoms of PTSD
Current Research
o Modafinil in the Treatment of PTSD (Posttraumatic Stress Disorder)
o Biomedical Research Foundation o National Center for Research Resources (NCRR)o National Institute of General Medical Sciences (NIGMS
)o The purpose of this study is to determine if modafinil
is more effective than placebo in the treatment of posttraumatic stress disorder (PTSD) in male combat veterans who have been deployed to Iraq or Afghanistan
Current Research
o Eszopiclone for the Treatment of Posttraumatic Stress Disorder
o Rush University Medical Center
o National Institute of Mental Health (NIMH)
o The purpose of this study is to determine if eszopiclone relative to placebo (sugar pill) is effective and tolerable for people with posttraumatic stress disorder (PTSD)-related sleep disturbance. The investigators will also examine the impact of treatment on sleep patterns, memory recall bias, and level of inflammatory markers (cytokines). The investigators predict eszopiclone will lead to greater improvement than placebo in measures of PTSD symptoms, memory recall bias, and level of inflammatory markers
PTSD Monies
o J $100M PTSD and TBI Study
o In a press release from September 19, 2012, the VA and DoD announced they are investing more than $100 million in research to improve diag nosis and treatment of mild traumatic brain injury (mTBI) and (PTSD)
o “At VA, ensuring that our veterans receive quality care is our highest pri ority,” said Secretary of Veterans Aff airs Eric K. Shinseki. “Investing in innovative research that will lead to treatments for PTSD and TBI is criti cal to providing the care our veterans have earned and deserve.”
PTSD Monies
o An executive order, signed by the President on August 31, 2012, was designed to improve access to mental health services for our veterans, ser vice members, and military families. In that order, the President directed the DoD, the VA, HHS, and the De partment of Education to develop a National Research Action Plan that will include strategies to improve early diagnosis and treatment effec tiveness for TBI and PTSD